Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

The Effect of Different Intra-canal Medications on Postoperative Pain

20 de julio de 2026 actualizado por: Maha Nasr, Cairo University

Evaluation of Postoperative Pain After Using Ibuprofen, Nitrofurantoin, or Calcium Hydroxide as Intracanal Medicaments in Root Canal Treatment of Necrotic Mandibular Posterior Teeth. A Randomized Controlled Trial

The aim of this study is to assess the effect of ibuprofen, nitrofurantoin, and calcium hydroxide on postoperative pain after endodontic treatment of necrotic mandibular posterior teeth

Research question/hypothesis:

In patients with necrotic pulps in their mandibular posterior teeth, there would be no difference in the incidence and/or severity of postoperative pain after the use of ibuprofen, nitrofurantoin, or calcium hydroxide intracanal medications.

The study will evaluate postoperative pain after using either of the tested drugs as an intracanal medication amidst visits. of endodontic treatment in cases where pulp necrosis is confirmed.

Descripción general del estudio

Descripción detallada

  • Trial design:

    • A Randomized controlled, double-blind, parallel-arm, clinical trial.
    • Allocation ratio 1:1:1
    • Framework: superiority
  • Study settings:

Outpatient clinic of Endodontics at the Faculty of Dentistry, Egyptian Russian University, Badr city, Cairo governorate, Egypt.

  • Eligibility criteria

    • Inclusion criteria:

      1. Patients with necrotic pulps.
      2. Adult, healthy patients, older than 18 years old
      3. Males and females.
      4. Patient with the ability to understand and use pain scales.
      5. Patient who accepts enroll to the study.
    • Exclusion criteria:

      1. Patients' allergies or any other contraindication to any of the medications used.
      2. Pregnant and lactating females.
      3. Patients have been taking pain medication 12 hours earlier.
      4. Patients who have more than one symptomatic mandibular tooth in the same quadrant.
      5. Patients with contributory medical history (ASA>II).
  • Diagnosis:

The diagnosis of pulp necrosis is confirmed through the patients' history, lack of response to cold testing and negative response to electric pulp tester whenever .The treatment will be done on two- visits.

• Treatment procedure: Each patient will be given an NRS chart to rate her /his presenting pain as preoperative pain. After complete mechanical preparation, each patient will be randomly assigned to either of three groups as follows, group 1: ibuprofen will be used as an intracanal medication, group 2: nitrofurantoin will be used as an intra canal medication and group 3: CaOH will be used as an intracanal medicament. The access cavity will be then sealed with temporary filling (MD-TEMP, META BIOMED CO., LTD. Chungbuuk, Korea). Post-operative instructions and appropriate post-operative rescue medication will be prescribed (400mg Ibuprofen). All patients will be asked to record their postoperative pain level felt on NRS at 6, 12, 24, 48, 72 hours and 7 days.

One week after the first visit, patients will be recalled to the clinic to complete their root canal treatment as recommended. All canals will be dried then obturated by the modified single cone technique using 0.04 taper gutta percha points and epoxy resin sealer. Patients will be referred to an operative or a fixed prosthodontics specialist for crown placement at the Faculty of Dentistry, Egyptian Russian University.

Research objective (state the aim) The aim of this study is to assess the effect of ibuprofen, nitrofurantoin and calcium hydroxide on postoperative pain after endodontic treatment of necrotic mandibular posterior teeth.

Sample size: (if calculation equation is used please state) A total of 111 patients, 37 per group needed for the clinical trial was calculated

Grouping & Randomization used:(specify if present) Three groups Group 1: ibuprofen Group 2: nitrofurantoin Group 3: calcium hydroxide

Outcome variables:

The primary outcome the effect of ibuprofen, nitrofurantoin and calcium hydroxide on postoperative pain after endodontic treatment of necrotic mandibular posterior teeth.

Postoperative pain will be measured using NRS at 6, 12, 24, 48, 72 hours postoperatively. Numerical Rating Scale (NRS) (20): It is an 11-point scale consisting of numbers from 0 through 10; - 0 reading represents "no pain" - 1-3 readings represent "mild pain" - 4- 6 readings represent "moderate pain" - 7- 10 readings represent "severe pain"

Tipo de estudio

Intervencionista

Inscripción (Estimado)

111

Fase

  • Fase temprana 1

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

    • Cairo Governorate
      • Cairo, Cairo Governorate, Egipto, 4450113
        • Reclutamiento
        • Faculty of Oral and Dental Medicine, Egyptian Russian University
        • Contacto:
        • Investigador principal:
          • Maha Nasr, Assistant Professor
        • Contacto:
          • Maha Nasr, Assistant professor
          • Número de teléfono: 01114367063
          • Correo electrónico: mahmouhaa87@gmail.com

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Adulto

Acepta Voluntarios Saludables

Sí

Descripción

Inclusion Criteria:

  1. Patients with necrotic pulps.
  2. Adult, healthy patients, older than 18 years old
  3. Males and females.
  4. Patient with the ability to understand and use pain scales.
  5. Patient who accepts enroll to the study.

Exclusion Criteria:

  1. Patients' allergies or any other contraindication to any of the medications used.
  2. Pregnant and lactating females.
  3. Patients have been taking pain medication 12 hours earlier.
  4. Patients who have more than one symptomatic mandibular tooth in the same quadrant.
  5. Patients with contributory medical history (ASA>II).

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Doble

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: ibuprofen
Ibuprofen. a NSAID, will be ground and formed into a paste to be placed inside the root canals of necrotic mandibular posterior teeth, to explore its effects on post-operative pain
Ibuprofen. a NSAID, will be ground and formed into a paste to be placed inside the root canals of necrotic mandibular posterior teeth, to explore its effects on post-operative pain
Experimental: nitrofurantoin
Nitrofurantoin tablets will be formed into a paste to be placed inside the root canals of necrotic mandibular premolars during endodontic treatment.
Comparador activo: calcium hydroxide
Calcium Hydroxide intracanal medicament will be placed inside the root canals of mandibular necrotic posterior teeth during endodontic treatment.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Intensity of Postoperative pain
Periodo de tiempo: Baseline (preoperative) and at 6, 12, 24, 48 and 72 hours after placement of the intracanal medicament.
Postoperative pain intensity will be self-reported by patients using an 11-point Numerical rating scale (NRS), where 0 represents "no paon" and 10 represents "the worst immaginable pain"
Baseline (preoperative) and at 6, 12, 24, 48 and 72 hours after placement of the intracanal medicament.

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Incidence of Postoperative pain
Periodo de tiempo: Up to 72 hours after placement of intracanal medicament
The percentage of patients experiencing any postoperative pain (NRS=0) within the follow-up period
Up to 72 hours after placement of intracanal medicament
Postoperative Analgesic Consumption
Periodo de tiempo: Up to 72 hours postoperatively
The total amount of prescribed analgesics consumed by the oatient. this will be measured by counting the total number of Ibuprofen 400 mg tablets taken by patients.
Up to 72 hours postoperatively

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

15 de diciembre de 2025

Finalización primaria (Estimado)

15 de febrero de 2027

Finalización del estudio (Estimado)

15 de marzo de 2027

Fechas de registro del estudio

Enviado por primera vez

18 de noviembre de 2025

Primero enviado que cumplió con los criterios de control de calidad

17 de mayo de 2026

Publicado por primera vez (Actual)

22 de mayo de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

21 de julio de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

20 de julio de 2026

Última verificación

1 de julio de 2026

Más información

Términos relacionados con este estudio

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

producto fabricado y exportado desde los EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir